Tech Company Financing Transactions
Stablepharma Funding Round
Stablepharma secured a $2.6 million investment round on 2/20/2025. Investors included European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
2/20/2025
Transaction Type
Debt
Amount
$2,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 Queen Street
Bath, BA1 1HE
UK
Bath, BA1 1HE
UK
Phone
Website
Email Address
Overview
Stablepharma is developing, potentially the world's first fridge-free vaccine SPVX02, a uniquely formulated pharmaceutical product for the prevention of Tetanus and Diphtheria.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Özgür Tuncer
Browse more venture capital transactions:
Prev: 2/20/2025: Relish venture capital transaction
Next: 2/20/2025: Henry AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs